Cytokinetics, Incorporated · NASDAQ:CYTK
Blum Robert I sold 105,426 Cytokinetics, Incorporated shares (Form 4)
Traded Sep 14 to Sep 15, 2026 · Filed Sep 15, 2026
From Sep 14 to Sep 15, 2026, Blum Robert I (Director, President & CEO) sold 105,426 Cytokinetics, Incorporated shares at an average US$69.62 for US$7.34M under a trading plan, leaving 0 shares. Filed Sep 15, 2026 (Form 4).
- Sold
- 105,426 shares
- Price
- US$69.62 average (US$69.33 to US$73.44)
- Value
- US$7.34M
- Holding after
- 0 shares (held indirectly)
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, President & CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 14, 2026 | Common Stock | Option exercise | 7,500 | US$10.60 | 385,320 | Direct |
| Sep 14, 2026 | Common Stock | Sale | 7,500 | US$73.44 | 377,820 | Direct |
| Sep 14, 2026 | Common Stock | Gift | 1,350 | 376,470 | Direct | |
| Sep 14, 2026 | Common Stock | Gift | 97,926 | 278,544 | Direct | |
| Sep 15, 2026 | Common Stock | Sale | 97,926 | US$69.33 | 0 | Indirect |
Source
Related
- Cytokinetics, Incorporated
- Blum Robert I
- Cytokinetics, Incorporated shareholders
- Form 4 · Blum Robert I · Oct 13, 2026
- Form 4 · Blum Robert I · Sep 28, 2026
- Form 4 · Blum Robert I · Aug 31, 2026
- Form 4 · Blum Robert I · Aug 10, 2026
- Form 4 · Blum Robert I · Jul 27, 2026
- Form 4 · Malik Fady Ibraham · Oct 20, 2026
- Form 4 · Daly James M · Oct 20, 2026
- Form 4 · Henderson John T · Oct 20, 2026
- Form 4 · Wysenski Nancy · Oct 20, 2026
- Form 4 · Harrington Robert Arthur · Oct 20, 2026